EUVIMEDEUVIMED entdecken
Crossref

Transcriptomic and Metabolomic Mechanism of Ibuprofen, Chondroitin Sulfate, and Vitamins With Minerals Tablets (21) for Kashin–Beck Disease Treatment

Jinfeng Wen iD, Xingxing Deng, Zhengjun Yang, Hui Niu, Qian Zhang, Yijun Zhao, Gaowa Naren, Huan Liu, Feng Zhang, Xiaodong Yang, Cuiyan Wu

Rapid Communications in Mass Spectrometry · 2025

DOI: 10.1002/rcm.10130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rapid Communications in Mass Spectrometry, 2025. Verfasst von Jinfeng Wen und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Health Science Center, Xi'an Jiaotong University, Key Laboratory of Environmental and Endemic Diseases of National Health Co…. Hauptthemen laut MEDLINE: Ibuprofen, Chondroitin Sulfates, Vitamins, Kashin-Beck Disease. Die Arbeit nennt 43 Literaturangaben. Gefördert von: National Key Research and Development Program, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Kashin–Beck disease (KBD) is an osteoarthropathy with no specific drug treatment. This study seeks to uncover the molecular mechanisms of ibuprofen, chondroitin sulfate, and vitamins with minerals tablets (21) in treating KBD.

Methods

Integrated transcriptomic and metabolomic analyses were performed on peripheral blood samples collected from four KBD patients before and 1 month after treatment. Differential gene expression was assessed using the DESeq package, while differential metabolites were identified through univariate and multivariate statistical analyses.

Results

After treatment, 5671 differential genes (|log 2 FC| ≥ 1, q < 0.05) were identified, with 4954 upregulated and 717 downregulated. Enriched pathways included PI3K‐Akt, MAPK, ECM‐receptor interaction, Rap1, and Ras signaling. Untargeted metabolomics analyses revealed five differentially expressed metabolites (VIP ≥ 1, |log 2 FC| > 0.58, p < 0.05): L‐glutamine, 2‐methylpropan‐2‐amine, epsilon‐caprolactam, phosphocholine, and 1‐palmitoyl‐2‐linoleoyl‐sn‐glycero‐3‐phosphocholine. Metabolite enrichment analysis suggested alterations in amino acid and fatty acid metabolism. Integrated analysis revealed key pathways such as alanine, aspartate, and glutamate metabolism and arginine biosynthesis.

Conclusions

The combination of ibuprofen, chondroitin sulfate, and vitamins with minerals tablets (21) may alleviate KBD through modulation of key genes (GDNF, BDNF, CCL2, VEGFA, and PPARG) and glutamine‐related metabolic pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IbuprofenChondroitin SulfatesVitaminsKashin-Beck DiseaseMineralsTranscriptomeHumansMetabolomicsMaleFemaleTabletsAdultMiddle AgedGene Expression ProfilingMetabolome

Stichwörter der Autor:innen

Kashin–Beck disease (KBD)drugs treatmentmetabolometranscriptome

Substanzen

IbuprofenChondroitin SulfatesVitaminsMineralsTablets

Autor:innen und Institutionen

  • School of Public Health, Health Science Center, Xi'an Jiaotong University, Key Laboratory of Environmental and Endemic Diseases of National Health Commission of the People's Republic of China, Xi'an, Shaanxi, China.
  • Sichuan Provincial People's Hospital East Sichuan Hospital and Dazhou First People's Hospital, Dazhou, China.
  • Shaanxi Provincial Center for Disease Prevention and Control, Xi'an, Shaanxi, China.
  • Department of Disease Prevention and Control, Lintong Rehabilitation and Convalescent Centre, Xi'an, Shaanxi, China.

ORCID-Profile: Jinfeng Wen

Förderung

  • National Key Research and Development Program
  • National Key Research and Development Program of China

Zitieren

APA

Wen, J., Deng, X., Yang, Z., Niu, H., Zhang, Q., Zhao, Y., Naren, G., Liu, H., Zhang, F., Yang, X., & Wu, C. (2025). Transcriptomic and Metabolomic Mechanism of Ibuprofen, Chondroitin Sulfate, and Vitamins With Minerals Tablets (21) for Kashin–Beck Disease Treatment. Rapid Communications in Mass Spectrometry. https://doi.org/10.1002/rcm.10130

Vancouver

Wen J, Deng X, Yang Z, Niu H, Zhang Q, Zhao Y, et al. Transcriptomic and Metabolomic Mechanism of Ibuprofen, Chondroitin Sulfate, and Vitamins With Minerals Tablets (21) for Kashin–Beck Disease Treatment. Rapid Communications in Mass Spectrometry. 2025. doi:10.1002/rcm.10130

BibTeX
@article{Wen2025,
  author = {Wen, Jinfeng and Deng, Xingxing and Yang, Zhengjun and Niu, Hui and Zhang, Qian and Zhao, Yijun and Naren, Gaowa and Liu, Huan and Zhang, Feng and Yang, Xiaodong and Wu, Cuiyan},
  title = {Transcriptomic and Metabolomic Mechanism of Ibuprofen, Chondroitin Sulfate, and Vitamins With Minerals Tablets (21) for Kashin–Beck Disease Treatment},
  journal = {Rapid Communications in Mass Spectrometry},
  year = {2025},
  doi = {10.1002/rcm.10130}
}
Kostenlos starten →